Keros Therapeutics, Inc.
KROS
Revenue
37.00k
▼-46.00k▼-55.42%
3 Months ChangeAssets
455.02M
▼-30.80M▼-6.34%
3 Months ChangeLiabilities
34.11M
▲2.23M▲7.01%
3 Months ChangeFree Cash Flow
-45.51M
▼-10.21M▼-28.92%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0001664710-24-000081
2024-09-30
Form 8-K
ID: 0001664710-24-000078
2024-09-03
Form 8-K
ID: 0001664710-24-000075
2024-08-28
Form 8-K
ID: 0001664710-24-000072
2024-08-07
Form 8-K
ID: 0001664710-24-000069
2024-08-07
Form 10-Q
ID: 0001664710-24-000068
2024-08-07
Form 8-K
ID: 0001664710-24-000067
2024-06-17
Form 8-K
ID: 0001664710-24-000059
2024-06-17
Form 8-K
ID: 0001664710-24-000058
2024-06-17
Form 8-K
ID: 0001664710-24-000055